3rd Quarter - Report
BROWN RUDNICK LLP for EXELA HOLDINGS, LLC
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Implementation of P.L. 112-144 (FDA Safety and Innovation Act) and P.L. 113 - 54 (Drug Quality and Security Act); Issues relating to ANDA approval
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN | — |
| LISA LAYMAN | — |
| HENRY W MENN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.